High-Flow Heated and Humidified Oxygen Therapy and Gastric Distension
HFHHNOGastric
Does High-Flow Heated and Humidified Nasal Oxygen Therapy (HFHHNO) Result in Gastric Distension? A Two-center Prospective Study
1 other identifier
interventional
60
1 country
1
Brief Summary
High Flow Heated and Humidified Nasal Oxygen therapy (HFHHNO) has been increasingly used in emergency medicine to assist patients with short term respiratory failure and to provide adequate oxygen to the body prior to intubation. Gastric distension which is the bloating of the stomach due to air being pumped into it is a concern for anesthesiologists as it increases the risk of nausea and vomiting during surgery (aspiration). The objective of this study is use an ultrasound machine to measure the volume of fluid in the stomach before and after HFNO is used in a standard clinical manner.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 16, 2017
CompletedFirst Posted
Study publicly available on registry
May 1, 2017
CompletedStudy Start
First participant enrolled
November 6, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 20, 2019
CompletedSeptember 10, 2019
February 1, 2019
1.4 years
February 16, 2017
September 6, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Gastric Volume
Ultrasound scan will be used to determine if there was an increase in gastric fluid volume following session of oxygen therapy.
Prior to, and immediately following session of HFHHNO oxygen therapy.
Secondary Outcomes (1)
Gastric Distension
Immediately following session of HFHHNO oxygen therapy.
Study Arms (1)
Study Arm
OTHERParticipants will undergo one session of high-flow heated and humidified oxygen therapy (HFHHNO) (up to 60-70 litre/min). They will undergo a gastric ultrasound scan after session of HFHHNO therapy.
Interventions
Participants will undergo one session of high-flow heated and humidified oxygen therapy (HFHHNO) (up to 60-70 litre/min). They will undergo a gastric ultrasound scan after session of HFHHNO therapy.
Eligibility Criteria
You may qualify if:
- Healthy volunteers aged 18 to 70 years
- Male or female
- American Society of Anesthesia physical status classification I and II
- Height greater than 145 cm
- Ability to understand the study protocol and provide informed consent. Communication difficulties will not be an impediment to participate. In case of a language barrier, translation services will be sought as per usual institutional practice.
You may not qualify if:
- Subjects predisposed to have an increased residual gastric volume at baseline (e.g. diabetes or known gastric dysmotility)
- History of major upper gastrointestinal disease (including hiatus hernia or prior gastroduodenal surgery)
- Morbid obesity (Body Mass Index \> 40 Kg/m2)
- Chronic Obstructive Pulmonary Disease (Emphysema or Chronic Bronchitis)
- Subjects diagnosed with type I and II Diabetes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Health Network, Torontolead
- Kaiser Permanentecollaborator
Study Sites (1)
Toronto Western Hospital
Toronto, Ontario, M5T 2S8, Canada
Related Publications (1)
McLellan E, Lam K, Behringer E, Chan V, Bozak D, Mitsakakis N, Perlas A. High-flow nasal oxygen does not increase the volume of gastric secretions during spontaneous ventilation. Br J Anaesth. 2020 Jul;125(1):e75-e80. doi: 10.1016/j.bja.2020.02.023. Epub 2020 Mar 31.
PMID: 32241548DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Anahi Perlas, MD
University Health Network, Toronto
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 16, 2017
First Posted
May 1, 2017
Study Start
November 6, 2017
Primary Completion
March 20, 2019
Study Completion
March 20, 2019
Last Updated
September 10, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share
No IPD is to be shared with other researchers. All data will be obtained during an gastric ultrasound scan.